These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26949001)

  • 1. Invasive fungal diseases in patients with acute lymphoid leukemia.
    Nicolato A; Nouér SA; Garnica M; Portugal R; Maiolino A; Nucci M
    Leuk Lymphoma; 2016 Sep; 57(9):2084-9. PubMed ID: 26949001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit.
    Doan TN; Kirkpatrick CM; Walker P; Slavin MA; Ananda-Rajah MR; Morrissey CO; Urbancic KF; Grigg A; Spencer A; Szer J; Seymour JF; Kong DC
    J Antimicrob Chemother; 2016 Feb; 71(2):497-505. PubMed ID: 26518050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors.
    Wiley JM; Smith N; Leventhal BG; Graham ML; Strauss LC; Hurwitz CA; Modlin J; Mellits D; Baumgardner R; Corden BJ
    J Clin Oncol; 1990 Feb; 8(2):280-6. PubMed ID: 2299371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary antifungal prophylaxis: decrease of invasive fungal disease incidence and reduction of risk factors in haematological patients in a 5-year retrospective study.
    Li Y; Liu M; Zhai B; Zhao X; Wang L; Li H; Wang S; Zhu H; Wang Q; Gao C; Huang W; Yu L
    Intern Med J; 2018 Jun; 48(6):713-720. PubMed ID: 29230923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis.
    Montesinos P; Rodríguez-Veiga R; Boluda B; Martínez-Cuadrón D; Cano I; Lancharro A; Sanz J; Arilla MJ; López-Chuliá F; Navarro I; Lorenzo I; Salavert M; Pemán J; Calvillo P; Martínez J; Carpio N; Jarque I; Sanz GF; Sanz MA
    Bone Marrow Transplant; 2015 Nov; 50(11):1465-72. PubMed ID: 26281032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary fungal prophylaxis in acute leukemia patients with different risk factors: retrospective analysis from the CAESAR study.
    Zhang R; Chen J; Huang H; Ma J; Meng F; Tang Y; Hu J; Zhang X; Ji Y; Ai H; Liang Y; Wu D; Huang X; Han M
    Int J Hematol; 2017 Aug; 106(2):221-228. PubMed ID: 28390035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study.
    Lerolle N; Raffoux E; Socie G; Touratier S; Sauvageon H; Porcher R; Bretagne S; Bergeron A; Azoulay E; Molina JM; Lafaurie M
    Clin Microbiol Infect; 2014 Nov; 20(11):O952-9. PubMed ID: 24861577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proven and probable invasive fungal infections in children with acute lymphoblastic leukaemia: results from an university hospital, 2005-2013.
    Sahbudak Bal Z; Yilmaz Karapinar D; Karadas N; Sen S; Onder Sivis Z; Akinci AB; Balkan C; Kavakli K; Vardar F; Aydinok Y
    Mycoses; 2015 Apr; 58(4):225-32. PubMed ID: 25728069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of hospital construction with the development of healthcare associated environmental mold infections (HAEMI) in pediatric patients with leukemia.
    Pokala HR; Leonard D; Cox J; Metcalf P; McClay J; Siegel J; Winick N
    Pediatr Blood Cancer; 2014 Feb; 61(2):276-80. PubMed ID: 23970381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia.
    Cornely OA; Leguay T; Maertens J; Vehreschild MJGT; Anagnostopoulos A; Castagnola C; Verga L; Rieger C; Kondakci M; Härter G; Duarte RF; Allione B; Cordonnier C; Heussel CP; Morrissey CO; Agrawal SG; Donnelly JP; Bresnik M; Hawkins MJ; Garner W; Gökbuget N;
    J Antimicrob Chemother; 2017 Aug; 72(8):2359-2367. PubMed ID: 28575414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary antifungal prophylaxis in hematological malignancy patients with previous invasive fungal disease: a retrospective analysis.
    Liu M; Li Y; Zhang Y; Zhao X; Zhai B; Zhang Q; Wang L; Zhao Y; Li H; Wang Q; Gao C; Huang W; Yu L
    PLoS One; 2014; 9(12):e115461. PubMed ID: 25531544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study.
    Harrison N; Mitterbauer M; Tobudic S; Kalhs P; Rabitsch W; Greinix H; Burgmann H; Willinger B; Presterl E; Forstner C
    BMC Infect Dis; 2015 Dec; 15():584. PubMed ID: 26715563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive fungal diseases in patients with new diagnosed acute lymphoblastic leukaemia.
    Gründahl M; Wacker B; Einsele H; Heinz WJ
    Mycoses; 2020 Oct; 63(10):1101-1106. PubMed ID: 32738006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.
    Kubiak DW; Bryar JM; McDonnell AM; Delgado-Flores JO; Mui E; Baden LR; Marty FM
    Clin Ther; 2010 Apr; 32(4):637-48. PubMed ID: 20435233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive fungal diseases impact on outcome of childhood ALL - an analysis of the international trial AIEOP-BFM ALL 2009.
    Lehrnbecher T; Groll AH; Cesaro S; Alten J; Attarbaschi A; Barbaric D; Bodmer N; Conter V; Izraeli S; Mann G; Möricke A; Niggli F; Schrappe M; Stary J; Zapotocka E; Zimmermann M; Elitzur S
    Leukemia; 2023 Jan; 37(1):72-78. PubMed ID: 36509893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential low-dose CT thorax scans to determine invasive pulmonary fungal infection incidence after allogeneic hematopoietic cell transplantation.
    Enger K; Tonnar X; Kotter E; Bertz H
    Ann Hematol; 2023 Feb; 102(2):413-420. PubMed ID: 36460795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: a 6-yr analysis from the cologne cohort for neutropenic patients.
    Vehreschild MJ; von Bergwelt-Baildon M; Tran L; Shimabukuro-Vornhagen A; Wisplinghoff H; Bangard C; Cornely OA; Vehreschild JJ
    Eur J Haematol; 2014 Nov; 93(5):400-6. PubMed ID: 24798021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience.
    Omer AK; Ziakas PD; Anagnostou T; Coughlin E; Kourkoumpetis T; McAfee SL; Dey BR; Attar E; Chen YB; Spitzer TR; Mylonakis E; Ballen KK
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1190-6. PubMed ID: 23747459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Retrospective Analysis of Invasive Fungal Diseases (IFD) of the Central Nervous System in Children With Lymphoid Malignancies.
    Ramanathan S; Kate S; Kembhavi S; Cheriyalinkal Parambil B; K C A; Bhat V; Prasad M; Moiyadi A; Biswas S; Narula G; Banavali S
    J Pediatr Hematol Oncol; 2020 May; 42(4):e202-e206. PubMed ID: 31815886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.